349PDynamics of clinical biomarkers as predictors of immunotherapy (IT) benefit in metastatic melanoma (MM) patients (pts) treated in reference institution. (25th November 2018) - Hernando, A; Dienstmann, R; Ortiz Velez, C; Villacampa, G; Ros Montañá, F J; Grau Béjar, J F; Garcia-Alvarez, A; Nuciforo, P G; Gros, A; Garcia-Patos, V; Bodet, D; Ferrer Fabrega, B; et al.